Detalhe da pesquisa
1.
Rare genetic variants in interleukin-37 link this anti-inflammatory cytokine to the pathogenesis and treatment of gout.
Ann Rheum Dis
; 79(4): 536-544, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32114511
2.
Anakinra for the treatment of acute gout flares: a randomized, double-blind, placebo-controlled, active-comparator, non-inferiority trial.
Rheumatology (Oxford)
; 2019 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30602035
3.
A systematic literature review of patient-reported outcome measures used in gout: an evaluation of their content and measurement properties.
Health Qual Life Outcomes
; 17(1): 63, 2019 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30975212
4.
Quality of care in gout: a clinical audit on treating to the target with urate lowering therapy in real-world gout patients.
Rheumatol Int
; 37(9): 1435-1440, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28748426
5.
2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.
Ann Rheum Dis
; 74(10): 1789-98, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26359487
6.
Erosive Hand OsteoArthritis (EHOA): analysis of consecutive patients presenting with EHOA in a hospital-based rheumatology practice and its implications for an upcoming interventional study.
Clin Rheumatol
; 41(6): 1833-1841, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35107653
7.
Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial.
Lancet Rheumatol
; 2(5): e270-e280, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33005902
8.
Gout lessons from 2018: CARES, a direct comparison of febuxostat vs allopurinol, and CANTOS, IL1 blocker for cardiovascular risk minimisation.
Clin Rheumatol
; 38(1): 263-265, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30542798
9.
Crystal-proven gout patients have an increased mortality due to cardiovascular diseases, cancer, and infectious diseases especially when having tophi and/or high serum uric acid levels: a prospective cohort study.
Clin Rheumatol
; 38(5): 1385-1391, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30929152
10.
A simple method for quantification of allopurinol and oxipurinol in human serum by high-performance liquid chromatography with UV-detection.
J Pharm Biomed Anal
; 45(2): 312-7, 2007 Oct 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-17890037
11.
Biochemical effectiveness of allopurinol and allopurinol-probenecid in previously benzbromarone-treated gout patients.
Clin Rheumatol
; 26(9): 1459-65, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17308859
12.
Personalizing treatment targets in rheumatoid arthritis by using a simple prediction model.
J Rheumatol
; 42(3): 398-404, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25593241
13.
2015 Gout Classification Criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.
Arthritis Rheumatol
; 67(10): 2557-68, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26352873
14.
Leflunomide for the treatment of rheumatoid arthritis in clinical practice: incidence and severity of hepatotoxicity.
Drug Saf
; 27(5): 345-52, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15061688
15.
Rituximab in cryoglobulinaemic vasculitis, evidence for its effectivity: a case report and review of literature.
Clin Rheumatol
; 30(2): 293-300, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21053035
16.
[The multidisciplinary practice guideline "The responsible use of biologicals"]. / Multidisciplinaire richtlijn "Verantwoord gebruik van biologicals".
Ned Tijdschr Geneeskd
; 155(30-31): A3114, 2011.
Artigo
em Holandês
| MEDLINE | ID: mdl-22085508
17.
New advances in the treatment of gout: review of pegloticase.
Ther Clin Risk Manag
; 6: 543-50, 2010 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-21127695
18.
Management of hyperuricemia in gout: focus on febuxostat.
Clin Interv Aging
; 5: 7-18, 2010 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-20169038
19.
An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.
Clin Ther
; 31(8): 1737-46, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19808132